ArriVent BioPharma, Inc. reports

Company location: Newtown Square, PA
Fiscal year end: 31 December

ArriVent BioPharma, Inc. has filed 152 SEC EDGAR filings since 23 Jun 2021

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 1-3 of 3 matching filings.

Per page

25

Current page

1

10-K File 001-41929

10-K

Filing date: 05 Mar 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-41929

10-K

Filing date: 03 Mar 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-41929

10-K

Filing date: 28 Mar 2024
Reporting date: 31 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .